Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation.
Source: MarketWatch
Sunday, 07. December 2025
Share:
11. November 2025 21:20
Why cutting drug prices is pushing Eli Lilly’s stock toward an all-time high
